FDA Drug Application (203615) for PRAMIPEXOLE DIHYDROCHLORIDE by ACTAVIS ELIZABETH

Back to FDA Applications sponsored by ACTAVIS ELIZABETH

Application Number203615
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage2.25MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NamePRAMIPEXOLE DIHYDROCHLORIDE
Active IngredientPRAMIPEXOLE DIHYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient PRAMIPEXOLE DIHYDROCHLORIDE3


Back to FDA Applications sponsored by ACTAVIS ELIZABETH